Private Capital Group’s Evolent Health EVH Stock Holding History

Private Capital Group’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-487	Closed	-$3K	–	2039
2020 Q1	$3K	Buy	+487	New	+$4.35K	﹤0.01%	1599

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Private Capital Group's EVH Position: Q2 2020 in Review

Private Capital Group sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 487 shares — an estimated $3K sold.

Private Capital Group first reported a position in EVH in Q1 2020 and held it in 1 quarter. The position peaked at $3K in Q1 2020. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

Private Capital Group reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
Private Capital Group sold 487 Evolent Health shares in Q2 2020, an estimated $3K.
Private Capital Group first reported a position in Evolent Health in Q1 2020 and held it in 1 quarter.
Private Capital Group's Evolent Health position peaked at $3K in Q1 2020.
136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Private Capital Group's 13F filing for Q2 2020, filed 13 Aug 2020.